TKMS: A Record Order Book That the Market Is Choosing to Ignore

Despite a 20% drop from August peak, TKMS' €20.1B backlog and raised guidance signal strength. Is the pullback a buying chance?

The disconnect is hard to miss. ThyssenKrupp Marine Systems has never had a stronger pipeline — a historic €20.1 billion backlog, two landmark contracts secured within days of each other, and guidance that has been lifted twice. Yet the shares are trading roughly 20 percent below the August peak, and the recent slide has done little to shake the conviction of those who see a buying opportunity rather than a red flag.

The Numbers Tell a Stronger Story Than the Chart

For investors willing to look past the daily noise, the fundamental picture is unusually robust. Revenue for the first nine months of the fiscal year 2025/26 climbed 19 percent to around €1.9 billion, while adjusted EBIT rose 13 percent to €110 million. Management now expects full-year sales growth of 10 to 12 percent — a substantial upgrade from the original 2 to 5 percent range — and an operating margin of up to 6.5 percent, slightly ahead of the prior consensus of 6.4 percent.

That €110 million profit figure, however, deserves careful handling. It reflects the completed nine-month period, not a projection for the full year. Conflating the two could lead investors to underestimate the strength of the final quarter — precisely the kind of nuance that matters when assessing whether the market has fully priced in the company's momentum.

Two Contracts That Changed the Trajectory

The foundation of the current optimism was laid in early July, when two developments landed almost simultaneously. On July 6, Canada selected TKMS as the preferred supplier for up to twelve submarines for the Royal Canadian Navy — a program with multi-decade implications. Two days later, on July 8, the German parliament's budget committee approved a contract for four MEKO A-200 DEU frigates with an option for four more, marking the largest surface vessel order in company history.

Together, these wins pushed the order backlog to a record €20.1 billion by the end of June. One market observer describes this as the strategic turning point of the year — one that matters far more than the recent price action suggests.

The Post-Rally Letdown

When TKMS presented its quarterly results in early August, the market responded with enthusiasm. Shares jumped double digits, and Bernstein Research upgraded the stock from Market-Perform to Outperform, lifting its price target from €76 to €125. Deutsche Bank also raised its rating around the same time.

But that enthusiasm may have overshot the mark. When a stock surges that quickly and guidance expectations become fully priced in, it takes very little to trigger profit-taking. Since late August, that is precisely what has unfolded. The shares crossed below their 20-day moving average about a week ago — a technical warning that likely prompted short-term traders to exit. The most recent session brought a 6.0 percent decline to €83.40, though no company-specific news, rating change, or identifiable catalyst accompanied the move.

That absence of a fundamental trigger points to technical consolidation rather than a deterioration in the business outlook. The stock now sits at around €83.60, just above its 200-day average of €83.48 and below its 50-day line of €86.32. On the week, the shares are down 8.4 percent.

Patience as a Strategy

For longer-term investors, the technical signals are less alarming than they appear. The relative strength index stands at 39.2, suggesting the stock is approaching oversold territory rather than overheating. Year-to-date, TKMS remains up 26 percent — hardly a picture of distress.

The company's strategic positioning also remains intact. Beyond the Canadian and German contracts, TKMS has been deepening its cooperation in the European naval sector, including the non-binding offer made in January for the Kiel-based German Naval Yards shipyard. For those who believe in long-term growth for Europe's defense industry, the current weakness may look more like a pause than a reversal.

What the market seems to be waiting for is explicit confirmation — concrete details on new orders or an updated backlog picture directly from the company. Until that arrives, the shares may continue to trade within their current range, caught between an exceptionally strong order book and the reality that expectations had simply run ahead of themselves. The underlying story — record contracts, raised guidance, and historic projects — has not changed. Only the level of investor enthusiasm has become more measured.